Another potent LSD1 inhibitor GSK2879552 (10) was found to exhibit high anti-proliferative activity against 20 out of 29 AML cell lines with EC50 values ranging from ~3–100 nM [103]. This evidence concerns the gene KDM1A and acute myeloid leukemia.